Ultra-low-dose same-target combinations control drug resistance across stages
Z.-G. Zhao, Shao-Qing Cai, R. Tan, W. Cai, Q. Zhao, X. Wang, F. Xu
This study shows that combining multiple low-dose inhibitors targeting the same oncogenic driver can delay drug resistance in cancer models.
bioRxiv · Nov 10, 2026 · PreprintCancer Biology